Complain about a product or service

FDA Warns P&G About Kids’ Hand Sanitizer

Active ingredient is an unapproved drug, FDA warns

September 19, 2007

• FDA Warns P&G About Kids’ Hand Sanitizer • Hygiene Habits Stall: Public Handwashing Down • Plain Soap and Water Still Best for Washing Hands • Handwashing Can Save Children's Lives, Study Finds

The U.S. Food and Drug Administration has sent a warning letter to Procter & Gamble for making unlawful claims about its Vicks Early Defense Foaming Hand Sanitizer product.

The agency says the product’s claims and directions for use cause it to be an unapproved new drug under the Federal Food, Drug, and Cosmetic Act.

It cited specifically Procter & Gamble promotion of Early Defense for use by schoolchildren to prevent colds and to provide anti-microbial activity for up to three hours.

Although FDA said it is not aware of significant health risks associated with Early Defense, the agency is concerned because this product has not been proven safe and effective for these claims.

“FDA is concerned with the marketing of this over-the-counter drug for use by school children and others,” said Steven K. Galson, M.D., M.P.H., director of FDA’s Center for Drug Evaluation and Research. “Over-the-counter (OTC) drugs are often widely used without supervision by a doctor or other health care professional, so it is essential that manufacturers obtain FDA approval or fully comply with OTC monographs and agency policies.”

Under its OTC drug monograph system, FDA allows OTC drugs to be marketed without first obtaining agency approval in certain circumstances. These drugs must comply with applicable standards regarding monographs that specify conditions for the drugs’ labeling and formulation.

OTC drugs that do not have FDA approval and do not meet these requirements are considered unapproved drugs that are unlawfully marketed.

There is a proposed OTC monograph that covers triclosan, the active ingredient in Early Defense. FDA allows companies to market their products, which would otherwise be unapproved new drugs, under proposed monographs, as long as the companies comply with the conditions in the proposed monograph.

In this case, the agency said the product's claims that it prevents colds and provides up to three hours of anti-microbial activity are not allowed under the proposed monograph.

Under the proposed monograph, when anti-microbial products use triclosan as their active ingredient, their labeling must direct consumers to rinse with water after use and Early Defense does not. Early Defense falls outside the proposed monograph and is considered an unapproved new drug because it lacks these directions and makes these impermissible claims.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.